ACCESSIBILITY

24/7

Headlines

16:24

Full list of Israeli high-tech funding rounds in 2025

16:21

Syremis raises $165 million Series A to take on schizophrenia and other severe mental illnesses

14:36

Iron Dome and Iron Beam maker Rafael moves closer to a possible IPO

14:20

Weapons as strategy: Israel’s defense industry steps into a larger global role

Buzz

Most popular

Daily

Weekly

Huang declares Israel Nvidia’s “second home” with record-breaking campus investment

Cyera raises $400 million at $9 billion valuation in Blackstone-led round

Dell acquires AI data-infrastructure startup Dataloop in $120 million all-cash deal

Vega raises $120 million Series B as two-year-old cyber startup hits $700 million valuation

“The acquisition of Armis marks a clear entry by ServiceNow into cybersecurity”

More news

IPO

11 stories about IPO

ForeScout Updates Prospectus, Targets a $942 Million Valuation for IPO

19.10.17|Dror Reich

The information security company aims to raise $96-$105.6 million in a Nasdaq IPO

Drug Conduction Company Prepares for Nasdaq IPO

08.10.17|Golan Hazani

Clinical stage PolyPid develops technology for the predetermined, controlled and localized release of drugs at a targeted site

Forescout Files For $100 Million Nasdaq IPO

04.10.17|Dror Reich

Underwriters for the intended initial public offering are Morgan Stanley and J.P. Morgan

Snap Partners With Advertising Company to Boost Revenue

03.10.17|Dror Reich and Amarelle Wenkert

The social platform partners with ad-tech company Perion’s creative ad division in attempt to boost ad revenue

Sisram Stock Price Down on Market Debut

19.09.17|Amarelle Wenkert

The Fosun Pharma subsidiary debuted on the Hong Kong Stock Exchange Tuesday

IPO Hopeful Entera Bio Moves to Better Position

13.09.17|Dror Reich

Clinical-stage company Entera Bio develops pioneering technology for orphan disease hypoparathyroidism

Train Safety Company Rail Vision Plans Nasdaq IPO

04.09.17|Golan Hazani

The company hopes to raise $25 million with a $100 million company valuation

Acne Cream Developer Sol-Gel files for $86 Million Nasdaq IPO

31.08.17|Dror Reich

The clinical-stage drug developer will remain a "controlled company" under current shareholder Arkin Dermatology

Anti-Acne Drug Developer Plans Nasdaq IPO

15.08.17|Golan Hazani

Sol-Gel approached potential underwriters. It aims to go public before the end of the year

Fosun Filed to Float Alma Lasers in Hong Kong

27.07.17|Golan Hazani and Meir Orbach

Fosun Pharma filed to list the medical equipment company it bought in 2013 on the Hong Kong Stock Exchange

Israeli Tech Exits Plummet in 2017, Report Says

06.07.17|Meir Orbach